Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
The Rock & Roll Hall of Fame Foundation Unveils Electrifying Class of 2025 Inductees
-
The Rock & Roll Hall of Fame Foundation Unveils Electrifying Class of 2025 Inductees
-
NOVONIX Appoints Michael O’Kronley as Chief Executive Officer
-
Perseus Mining Proceeds with Development of Nyanzaga Gold Project
-
Alkane and Mandalay Combine to Create Growing Gold and Antimony Producer
-
BDTCOIN (BDTC) Is Listed On AscendEX! Trade Now!
-
Studies Explore How New Treatments, Metabolic Health and Weight Loss Shape Sexual Wellness for Men and Women
-
Precede Biosciences Presents Data at AACR 2025 Demonstrating Ability to Resolve Gene Expression for Thousands of Tumor-Specific Genes from a Simple Blood Test
-
Y-mAbs Presents Translational Pharmacokinetics of CD38-SADA from Pretargeted RIT Platform at 2025 American Association for Cancer Research (AACR) Annual Meeting
-
XRP News: XenDex Fills Up More Than 30% of Its Presale as Community Activity Grows Rapidly
-
The Day After Canada Votes, 500 Innovation Leaders Gather to Chart the Country’s Economic Future
-
Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell Engager
-
Studies Link Lifestyle, Exercise and Yoga to Improved Urologic Health and Cancer Outcomes
-
Revolution Medicines Presents Initial Data from Zoldonrasib (RMC-9805) Study in Patients with KRAS G12D Mutant Non-Small Cell Lung Cancer at the 2025 AACR Annual Meeting
-
Studies Showcase Women’s and Children’s Bladder Health—From Early Symptoms to Innovative Treatments
-
SpringWorks Therapeutics Announces Expected CHMP Opinion in Q2 2025 for Nirogacestat for the Treatment of Adults with Desmoid Tumors in the European Union
-
SpringWorks Therapeutics Announces Expected CHMP Opinion in Q2 2025 for Nirogacestat for the Treatment of Adults with Desmoid Tumors in the European Union
-
The Tryst Puerto Vallarta Throws an Unforgettable Star-Studded Grand Opening Weekend
-
Risk Strategies acquires GMC Advisors, LLC
-
UPDATE -- Relmada Therapeutics To Present NDV-01 Data at AUA2025
-
Dr. Tamara Moodie LLC Launches Three New Autism-Focused Publications to Support Empathy, Awareness, and Inclusivity
-
2025 (Spring) Pharmaceutical Machinery Exposition Concludes Successfully
-
CraveU AI: Launches New AI Girlfriend for Realistic Virtual Companionship
-
CoinEx Wins “Best Mobile App for Crypto Trading Asia 2025” by International Business Magazine
-
XRP News: XploraDEX $XPL Presale Nears Completion as Final Countdown 48 Hours Begins
-
Three-Year Data of Zenflow’s Spring System Demonstrate Durability of Clinical Benefits for Patients Suffering from BPH
-
CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at the American Urological Association Annual Meeti
-
IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025
-
Studies Uncover Hidden Urologic Risks—How Water, Chemicals and Everyday Exposures Impact Urinary Health
-
FOMO Builds As Bitcoin Briefly Shoots Above $94K; Investors Shift To Earn BTC Through Zaminer Cloud Mining Site
-
FOMO Builds As Bitcoin Briefly Shoots Above $94K; Investors Shift To Earn BTC Through Zaminer Cloud Mining Site
-
RAINN Statement on the Passing of Virginia Giuffre
-
Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities
-
Studies Unveil Groundbreaking Advances in Prostate Cancer: From AI-Driven Detection to Non-Invasive Testing
-
ESA Pet: A Trusted Provider of ESA Letters for California Residents
-
XRP News: Crypto Analysts Predict $XDX Presale Sellout Within 10 Days as Over 20% Fills in First 24 Hours
-
New share capital registered
-
No KYC. 100x Leverage. $50 Welcome Bonus. Crypto Futures Trading Made Easy on BexBack.
-
Studies Show Breakthroughs in Male Contraception, Including First Male Contraceptive Hydrogel
-
ESA Pet Streamlines Getting ESA Letters by Real Therapists
-
These 5 AI trends Will Shape 2025, Says New Report
-
Protara Therapeutics Announces Positive Interim Results Demonstrating Durable Responses in the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC
-
798 Art District and Beijing International Film Festival Jointly Launch “Art Lights the Screen” – A Cultural Feast of Film and Art
-
Summons for the Annual General Meeting of P/F Atlantic Petroleum
-
XRP News: XploraDEX XPL Presale and Token Distribution Enter Final 48 Hours—Last Chance to Join XRP’s Most Innovative DEX
-
GenVivo Highlights GEN-1013: A Novel Delivery of an IL-12 Immunotherapy at the 2025 American Association for Cancer Research (AACR) Annual Meeting
-
XRP News: XenDex Community Rises in Thousands as XRP Investors Race to Secure Remaining Presale Tokens
-
Levicept Presents Positive Phase II Data for Novel Neurotrophin-3 Inhibitor, LEVI-04, at 2025 World Congress on Osteoarthritis
-
From Holding to Adding Value: New Strategies for XRP Investors and JA Mining’s Cloud Solutions
-
DNMiner Empowers Crypto Enthusiasts to Achieve Financial Freedom with Trusted Mining Hardware and Hosting Solutions

